BPC-157 – 10MG
$89.00
Buy BPC-157 in Canada — a 15-amino acid gastric peptide studied for tendon repair, gut healing, and neuroprotection. ≥99% purity, HPLC-verified, supplied as lyophilized powder. For licensed research use only.
What Is BPC-157? Benefits & Overview
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a protective protein found in human gastric juice. One of the most extensively studied regenerative peptides available in Canada, BPC-157 has been the subject of peer-reviewed investigations spanning tendon repair, gut mucosal healing, angiogenesis, and neuroprotection — making it a top choice for those exploring advanced peptide protocols.
Its sequence — Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val — is stable in gastric acid and demonstrates activity across multiple tissue compartments in animal models, making it a versatile tool for repair biology research.
BPC-157 Benefits & Uses
- Tendon, ligament, and muscle tissue regeneration models
- Gastrointestinal mucosal healing and IBD research
- Nitric oxide and growth factor (VEGF, EGF) signaling studies
- Neuroprotection and CNS injury response models
- Anti-inflammatory pathway research (NF-κB modulation)
- Bone healing and fracture repair studies
How BPC-157 Works
BPC-157 exerts pleiotropic effects through several interconnected pathways. It upregulates the nitric oxide (NO) system, stimulating vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) to accelerate angiogenesis at injury sites. It also modulates the FAK-paxillin pathway, enhancing tendon cell migration and proliferation. In gastrointestinal models, BPC-157 stabilises the gut-brain axis via vagus nerve interactions and promotes mucin secretion to protect and repair the mucosal lining.
BPC-157 10mg Vial Specifications
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular Formula: C₆₂H₉₈N₁₆O₂₂
- Molecular Weight: 1,419.5 Da
- Purity: ≥99% (third-party HPLC verified)
- Form: Lyophilized powder
- Vial Size: 10 mg
- Storage: −20 °C (long-term); 4 °C (short-term, up to 4 weeks)
- Reconstitution: Bacteriostatic water or sterile saline
Why Buy BPC-157 from Reviv Peptides
Reviv Peptides is a Canadian-based peptides supplier committed to pharmaceutical-grade quality. Every BPC-157 vial is independently tested by a third-party laboratory for identity (MS), sequence fidelity, and purity (HPLC) before dispatch. We ship across Canada with discreet, temperature-appropriate packaging and provide Certificates of Analysis (CoA) on request.
BPC-157 Canada FAQs
Is BPC-157 legal to buy in Canada?
BPC-157 is not a controlled substance in Canada.
What purity is your BPC-157?
Our BPC-157 is independently verified at ≥99% purity via third-party HPLC analysis. Certificates of Analysis are available upon request.
How should BPC-157 be stored?
Store lyophilized BPC-157 at −20 °C for long-term preservation. Once reconstituted with bacteriostatic water, store at 4 °C and use within 28 days.
What is the difference between BPC-157 and TB-500?
BPC-157 primarily targets gastrointestinal and connective tissue repair via NO and VEGF signalling, while TB-500 (Thymosin Beta-4 analog) drives tissue repair through actin upregulation and angiogenesis. Many researchers study them in combination — see our Wolverine Stack.
Reconstitution & Dosing Guide
How to Reconstitute
Add 3.0 mL of bacteriostatic water to the vial. Inject the water slowly down the inside wall of the vial — do not inject directly onto the powder. Gently swirl until fully dissolved; do not shake. This yields approximately 3.33 mg/mL. Store the reconstituted vial at 4 °C and use within 28 days.
Low Starting Dose
- Dose per injection: 200 mcg — 6 units (0.06 mL) on a U-100 insulin syringe
- Frequency: Once daily, subcutaneous injection
- Cycle length: 8–12 weeks
Inject near the target site or in the abdomen.
Start at the lowest effective dose and adjust based on individual response. Consult a qualified healthcare professional before use.

Reviews
There are no reviews yet.